Literature DB >> 8877534

CAT III chloramphenicol resistance in Pasteurella haemolytica and Pasteurella multocida isolated from calves.

C Vassort-Bruneau1, M C Lesage-Descauses, J L Martel, J P Lafont, E Chaslus-Dancla.   

Abstract

Chloramphenicol, which had been used extensively for antimicrobial veterinary therapy, was prohibited in Europe in 1994. Soon after it became available, resistance to this drug was detected, generally conferred by plasmids encoding inactivating enzymes, the chloramphenicol acetyltransferases (CAT), in Gram-negative as well as in Gram-positive bacteria. In the last few years, resistance to antibiotics emerged in Pasteurella strains from breeding herds and this evolution was followed by a national surveillance network. Chloramphenicol-resistance was more recently detected in multiresistant strains. We studied 25 strains of Pasteurella, selected for their resistance to chloramphenicol. Production of a CAT was demonstrated in all these strains. PCR amplification indicated that the CAT produced was of type III for 23 of them. In these strains, chloramphenicol-resistance was mediated by plasmids of about 5.1 kb. Southern blots on restriction fragments suggested a high degree of homology between these 5.1 kb plasmids. In the two other strains, production of a CAT type I was demonstrated, and the corresponding genes were either shown on a plasmid of 17 or 5.5 kb.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877534     DOI: 10.1093/jac/38.2.205

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Characterization of chloramphenicol resistance in beta-hemolytic Escherichia coli associated with diarrhea in neonatal swine.

Authors:  Kenneth M Bischoff; David G White; Patrick F McDermott; Shaohua Zhao; Stuart Gaines; John J Maurer; David J Nisbet
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Characterization of chloramphenicol and florfenicol resistance in Escherichia coli associated with bovine diarrhea.

Authors:  D G White; C Hudson; J J Maurer; S Ayers; S Zhao; M D Lee; L Bolton; T Foley; J Sherwood
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Comparison of the prevalences and antimicrobial resistances of Escherichia coli isolates from different retail meats in the United States, 2002 to 2008.

Authors:  S Zhao; K Blickenstaff; S Bodeis-Jones; S A Gaines; E Tong; P F McDermott
Journal:  Appl Environ Microbiol       Date:  2012-01-13       Impact factor: 4.792

Review 4.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Antimicrobial susceptibility and molecular detection of chloramphenicol and florfenicol resistance among Escherichia coli isolates from diseased chickens.

Authors:  Xin Sheng Li; Gui Qin Wang; Xiang Dang Du; Bao An Cui; Su Mei Zhang; Jian Zhong Shen
Journal:  J Vet Sci       Date:  2007-09       Impact factor: 1.672

6.  Antimicrobial resistance in equine faecal Escherichia coli isolates from North West England.

Authors:  Mohamed O Ahmed; Peter D Clegg; Nicola J Williams; Keith E Baptiste; Malcolm Bennett
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-04-07       Impact factor: 3.944

7.  Serological Variety and Antimicrobial Resistance in Salmonella Isolated from Reptiles.

Authors:  Lina Merkevičienė; Česlova Butrimaitė-Ambrozevičienė; Gerardas Paškevičius; Alma Pikūnienė; Marius Virgailis; Jurgita Dailidavičienė; Agila Daukšienė; Rita Šiugždinienė; Modestas Ruzauskas
Journal:  Biology (Basel)       Date:  2022-05-29

8.  Comparative Genomic Analysis of the Human Pathogen Wohlfahrtiimonas Chitiniclastica Provides Insight Into the Identification of Antimicrobial Resistance Genotypes and Potential Virulence Traits.

Authors:  Anna Kopf; Boyke Bunk; Sina M Coldewey; Florian Gunzer; Thomas Riedel; Percy Schröttner
Journal:  Front Cell Infect Microbiol       Date:  2022-07-07       Impact factor: 6.073

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.